MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-HR-10-0007521
Xieon Life Sciences Private Limited - pharma in Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹43.18 Cr
▲ 18% YoY
Net profit · FY 2024
₹1.32 Cr
Net margin 3.1%
EBITDA · FY 2024
₹2.15 Cr
EBITDA margin 5%
Authorised capital
₹2 Cr
Registered with MCA
Paid-up capital
₹2 Cr
Issued & subscribed
Open charges
₹3 Cr
Satisfied ₹2 Lakh
Company age
19 yrs
Est. 2007
Directors on board
4
As per MCA filings
About Xieon Life Sciences Private Limited
Data last updated:
Xieon Life Sciences Private Limited is a private limited company based in Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 14 February 2007 and has been in existence for over 19 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51101DL2007PTC159289. Its GSTIN is 06AAACX0502H1ZU (Haryana).
The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹2 Cr. It was formerly known as Xieon Lifesiences Private Limited. It is led by directors including Yogesh Singla (Managing Director) and Ashok Bambha.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 353/29 Onkar Nagar – B Tri Nagar, Delhi, India – 110035.
As per the financials filed for FY 2024, the company reported a revenue of ₹43.18 Cr, a growth of 18% compared to the previous year. For the same year it recorded a net profit of ₹1.32 Cr (net margin 3.1%) and EBITDA of ₹2.15 Cr (EBITDA margin 5%). Revenue has grown at a compounded annual rate (CAGR) of 7% over three years and 14% over five years.
The company is associated with 3 brands: Merrybell Bioceuticals, Xieon and Xieon Life Sciences. As per MCA filings, the company has open charges of ₹3 Cr and satisfied charges of ₹2 Lakh on record. Court records list 10 cases involving the company, including 10 filed by the company; 2 cases are pending.
Xieon Life Sciences Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-10-0007521). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website xieonlife.com.
Company details
CIN U51101DL2007PTC159289
Registration Number 159289
Incorporation Date 14 February 2007
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-HR-10-0007521
Recognitions & Rankings of Xieon Life Sciences
Contact details
Xieon Life Sciences Private Limited's registered office is in Delhi, Delhi. Its website is xieonlife.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address353/29 Onkar Nagar – B Tri Nagar, Delhi, India – 110035
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Xieon Life Sciences Private Limited, buy the company report.
Comprehensive company report
Xieon Life Sciences Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Xieon Life Sciences operates multiple associated brands including Merrybell Bioceuticals, Xieon, and Xieon Life Sciences. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures and markets pharmaceutical products including tablets, capsules, and ointments worldwide. | merrybellbioceuticals.com | |
| Manufactures and markets pharmaceutical products, including tablets and capsules, worldwide. | ecolifecare.in | |
| Serves as a contract manufacturer and exporter of pharmaceuticals and related products. | xieonlife.com |
Business activity
The main business activity of Xieon Life Sciences is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Xieon Life Sciences Private Limited, buy the company report.
Financials of Xieon Life Sciences Private Limited
FY 2024 filings availableXieon Life Sciences Private Limited reported revenue of ₹43.18 Cr (up 18% YoY) for FY 2024.
Revenue · FY 2024
₹43.18 Cr ▲ 18%
Net profit · FY 2024
₹1.32 Cr margin 3.1%
EBITDA · FY 2024
₹2.15 Cr margin 5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 18%
3 years · compounded
▲ 7%
5 years · compounded
▲ 14%
EBITDA CAGR growth
1 year
▲ 32%
3 years · compounded
▲ 37%
5 years · compounded
▲ 41%
Revenue has grown at a compounded annual rate (CAGR) of 14% over five years, including 18% growth in the latest year. EBITDA rose 32% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹43.18 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.15 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.32 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5% | ||||
| Net Profit Margin | 3.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Xieon Life Sciences Private Limited, buy the company report.
Board of directors of Xieon Life Sciences Private Limited
Xieon Life Sciences has 4 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ashok Bambha Also directs: Xieon Healthcare Private Limited | Director | 01 May 2010 | 16 Years 5 Months | Current |
| Ankur Goyal Also directs: Xieon Healthcare Private Limited, GMH Pharmaceuticals Pvt Ltd, Kingston Aqua Industries Private Limited. and 1 more | Director | 14 Feb 2007 | 19 Years 8 Months | Current |
| Yogesh Singla Also directs: Xieon Healthcare Private Limited | Managing Director | 14 Feb 2007 | 19 Years 8 Months | Current |
| Manoj Singla | Director | 10 Oct 2025 | 1 Years 0 Months | Current |
Peer comparison
Xieon Life Sciences Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sangharsh Lifecare Private Limited | ₹43.47 Cr (FY 2025) | 56.0% | Ahmedabad, Gujarat, India | |||
| Aprazer Healthcare Private Limited | ₹43.41 Cr (FY 2024) | 11.0% | New Delhi, Delhi, India | |||
| Xieon Life Sciences Private Limitedthis company | ₹43.18 Cr (FY 2024) | ₹1.32 Cr | 3.1% | 18.0% | Delhi, India | |
| Dheer Health Care Private Limited | ₹42.88 Cr (FY 2024) | 25.0% | Mumbai, Maharashtra, India | |||
| Waterley Pharmaceuticals Private Limited | ₹42.86 Cr (FY 2025) | 24.0% | Secunderabad, Telangana, India |
To see the full peer comparison of Xieon Life Sciences Private Limited, buy the company report.
Auditor
Xieon Life Sciences Private Limited is audited by ANURAG KHANNA for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ANURAG KHANNA | FY 2024 | 512943 |
Shareholding
The shareholding of Xieon Life Sciences Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Xieon Life Sciences Private Limited, buy the company report.
Charges & borrowings
Open charges
₹3 Cr
Satisfied charges
₹2 Lakh
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 11 Mar 2015 | 10565794 | Others | ₹3 Cr | Open | |
| 03 Nov 2008 | 10130946 | Punjab National Bank | ₹2 Lakh | Satisfied |
To see the full charge records of Xieon Life Sciences Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
Xieon Life Sciences Private Limited has 10 court cases on record: 10 filed by Xieon Life Sciences. 2 cases are pending and 8 are disposed.
Total cases
10
Filed by the company
10
Pending
2
Disposed
8
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 10 | 0 | 2 |
Cases on record (5 of 10)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Karnal, Haryana | Cheque dishonour complaint | Filed by the company against M/S Healthy Amide Line Pharma | Pending |
| District court, Karnal, Haryana | Cheque dishonour complaint | Filed by the company against M/S Novovista Pharmaceuticals | Pending |
| District court, Karnal, Haryana | Cheque dishonour complaint | Filed by the company against M/S Akhil Pharma and 1 other | Disposed |
| District court, Karnal, Haryana | Cheque dishonour complaint | Filed by the company against M/S Ganesh Pharma and 3 others | Disposed |
| District court, Karnal, Haryana | Civil suit | Filed by the company against M/S A R Saless | Disposed |
To see the full case history of Xieon Life Sciences Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Xieon Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Xieon Life Sciences has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAACX0502H1ZU | Haryana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Xieon Life Sciences Private Limited, buy the company report.
Recent activity
Xieon Life Sciences Private Limited has 6 board changes on record since 2007: 4 appointments and 2 cessations. The latest: Manoj Singla was appointed as Director on 10 Oct 2025.
Appointed
Manoj Singla was appointed as Director.
AGM
Xieon Life Sciences Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Xieon Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
Charges
A charge registered on 03 Nov 2008 via Charge ID 10130946 with Punjab National Bank was fully satisfied on 22 Nov 2022.
Charges
A charge with Others of Rs. 3.00 Cr registered on 11 Mar 2015 with Charge ID 10565794 was modified on 28 Oct 2022.
Charges
A charge with Others amounted to Rs. 3.00 Cr with Charge ID 10565794 was registered on 11 Mar 2015.
Ceased
Yogesh Singla ceased to be Director.
Ceased
Aman Bambha ceased to be Director.
Appointed
Ashok Bambha was appointed as Director.
Charges
A charge with Punjab National Bank amounted to Rs. 0.02 Cr with Charge ID 10130946 was registered on 03 Nov 2008.
Appointed
Ankur Goyal was appointed as Director.
Appointed
Yogesh Singla was appointed as Managing Director.
1 earlier event is in the company report.
Frequently asked questions
Xieon Life Sciences is an active private limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 14 February 2007 (19+ years old) and is registered under CIN U51101DL2007PTC159289.
Xieon Life Sciences has 4 current directors:
- Yogesh Singla - Managing Director
- Ashok Bambha - Director
- Ankur Goyal - Director
- Manoj Singla - Director
The latest financial statements of Xieon Life Sciences on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Xieon Life Sciences is 06AAACX0502H1ZU, registered in Haryana.
The CIN (Corporate Identification Number) of Xieon Life Sciences is U51101DL2007PTC159289. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Xieon Life Sciences has 10 court cases on record: 10 filed by the company. 2 are pending.
Xieon Life Sciences was incorporated on 14 February 2007, making it 19+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Xieon Life Sciences by revenue are Sangharsh Lifecare Private Limited, Aprazer Healthcare Private Limited, Dheer Health Care Private Limited, Waterley Pharmaceuticals Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (wholesale trading).
Manoj Singla was appointed as Director on 10 Oct 2025. Yogesh Singla ceased to be Director on 01 Aug 2010. Aman Bambha ceased to be Director on 01 May 2010. Xieon Life Sciences has 6 board changes on record in total.
Yes, Xieon Life Sciences is registered as a small enterprise under Udyam registration (number: UDYAM-HR-10-0007521).
Xieon Life Sciences can be reached through the website xieonlife.com. Its registered office is in Delhi, India.